Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(20/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(20/week)
News
United States
(579/week)
Manufacturing
(424/week)
Energy
(320/week)
Technology
(448/week)
Other Manufacturing
(341/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
ARMO BioSciences, Inc.
Jun 22, 2018
Lilly Completes Acquisition of ARMO BioSciences
May 10, 2018
Lilly Announces Agreement To Acquire ARMO BioSciences
Jan 25, 2018
ARMO BioSciences Announces Pricing of Initial Public Offering
Dec 29, 2017
ARMO BioSciences Files Registration Statement for Proposed Initial Public Offering
Dec 09, 2017
ARMO BioSciences Presents Data from its Phase 1b Trial in Non-Small Cell Lung Cancer at ESMO Immuno Oncology Congress 2017
Dec 08, 2017
ARMO BioSciences Presents Efficacy Data from its Phase 1b Trial in Patients with Metastatic Renal Cell Carcinoma at ESMO Immuno-Oncology Congress 2017
Nov 28, 2017
ARMO BioSciences Appoints Herb Cross as Chief Financial Officer
Oct 09, 2017
ARMO BioSciences Appoints Immuno-Oncology Industry Veteran Joseph Leveque, M.D., as Chief Medical Officer
Sep 09, 2017
ARMO BioSciences's Phase 1b Trials Demonstrate Continued Promising Response Rates and Survival in Patients with Advanced Pancreatic Cancer, NSCLC, and RCC
Aug 29, 2017
ARMO BioSciences Raises $67 Million in a Series C-1 Financing
Jun 29, 2017
ARMO BioSciences Presents Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer at ESMO World Congress on Gastrointestinal Cancer 2017
Jun 28, 2017
ARMO BioSciences Appoints Naiyer A. Rizvi, M.D. to Board of Directors
Jun 03, 2017
ARMO BioSciences Announces Promising Response Rates and Survival Data in Patients with Advanced NSCLC and RCC from Phase 1/1b Trial for Immunotherapy AM0010 with Checkpoint Inhibitors
Jun 03, 2017
ARMO BioSciences Announces Encouraging Survival Data Observed in Patients with Advanced Pancreatic Cancer in Phase 1/1b Trial of Immunotherapy AM0010
May 30, 2017
ARMO BioSciences to Present at the Jefferies 2017 Global Healthcare Conference
Latest News
Apr 28, 2024
AngleLock to Introduce World's First 7th Axis Linear Shaft Motor Gantry for Industry 4.0 at Automate...
Apr 28, 2024
Conditioned Air Association of Georgia Announces "Top 20 under 40" List Recognizing HVAC Industry...
Apr 28, 2024
Dubai begins construction of 'world's largest' airport terminal
Apr 28, 2024
HII’s Ingalls Shipbuilding Hosts Inaugural Scout Merit Badge Day
Apr 27, 2024
Summit Energy Sponsors and Participates in the Interfaith Social Services Stop the Stigma 5K
Apr 27, 2024
Owens Corning and Masonite Extend Early Participation Deadline and Announce Successful Results of Early...
Apr 27, 2024
Faraday Future Announces Nasdaq Delisting Determination and Intention to Appeal
Apr 27, 2024
Macron ready to 'open debate' on nuclear European defence
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events